氧化脂质谱与1型糖尿病发生相关:DAISY研究
在DAISY前瞻性队列中嵌套病例对照分析,检测72例1型糖尿病病例和71名对照的血浆氧化脂质。ARA来源的5-HETE与风险升高相关,LA、ALA和DHA来源的多种氧化脂质与风险降低相关;PC1(LA/ALA来源升高)OR 0.61,PC2(ARA来源升高)OR 1.53。关键时间点分析显示ARA来源氧化脂质谱仅在自身抗体血清转换后与1型糖尿病相关。
要点
- LA和ALA来源氧化脂质谱与1型糖尿病风险降低相关(PC1 OR 0.61)。
- ARA来源氧化脂质谱与1型糖尿病风险升高相关(PC2 OR 1.53)。
- ARA相关氧化脂质的作用主要体现在自身抗体血清转换后。
核心结论
- LA和ALA相关氧化脂质升高与1型糖尿病风险降低相关,提示炎症促进与消退均参与1型糖尿病。
- ARA相关促炎氧化脂质可能在自身免疫过程启动后发挥重要作用。
研究设计与样本
- 在DAISY前瞻性队列中开展嵌套病例对照分析,纳入72例1型糖尿病病例和71名对照。
- 对照按病例自身抗体血清转换时年龄、种族和样本可用性进行频数匹配。
- 采用线性混合模型获取年龄校正均值,用logistic回归分析关联,并校正高风险HLA基因型HLA-DR3/4,DQB1*0302。
- 对氧化脂质进行主成分分析,并检验主成分与1型糖尿病的关联。
主要发现
- ARA相关氧化脂质5-HETE与1型糖尿病风险升高相关。
- 五种LA相关、两种ALA相关和一种DHA相关氧化脂质与1型糖尿病风险降低相关。
- LA和ALA相关氧化脂质升高的谱(PC1)与1型糖尿病风险降低相关(OR 0.61;95% CI 0.40, 0.94)。
- ARA相关氧化脂质升高的谱(PC2)与糖尿病风险升高相关(OR 1.53;95% CI 1.03, 2.29)。
- 关键时间点分析显示,1型糖尿病与自身抗体血清转换后而非转换前的ARA相关氧化脂质高谱相关。
临床怎么用
- 氧化脂质谱可能作为1型糖尿病风险分层和发病机制研究的候选生物标志物。
- LA和ALA相关氧化脂质与风险降低相关,提示炎症消退通路值得进一步研究。
- ARA相关氧化脂质在自身抗体血清转换后与风险升高相关,提示监测时间窗的重要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Oxylipins are lipid mediators derived from polyunsaturated fatty acids. Some oxylipins are proinflammatory (e.g. those derived from arachidonic acid [ARA]), others are pro-resolving of inflammation (e.g. those derived from α-linolenic acid [ALA], docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]) and others may be both (e.g. those derived from linoleic acid [LA]). The goal of this study was to examine whether oxylipins are associated with incident type 1 diabetes. METHODS: We conducted a nested case-control analysis in the Diabetes Autoimmunity Study in the Young (DAISY), a prospective cohort study of children at risk of type 1 diabetes. Plasma levels of 14 ARA-derived oxylipins, ten LA-derived oxylipins, six ALA-derived oxylipins, four DHA-derived oxylipins and two EPA-related oxylipins were measured by ultra-HPLC-MS/MS at multiple timepoints related to autoantibody seroconversion in 72 type 1 diabetes cases and 71 control participants, which were frequency matched on age at autoantibody seroconversion (of the case), ethnicity and sample availability. Linear mixed models were used to obtain an age-adjusted mean of each oxylipin prior to type 1 diabetes. Age-adjusted mean oxylipins were tested for association with type 1 diabetes using logistic regression, adjusting for the high risk HLA genotype HLA-DR3/4,DQB1*0302. We also performed principal component analysis of the oxylipins and tested principal components (PCs) for association with type 1 diabetes. Finally, to investigate potential critical timepoints, we examined the association of oxylipins measured before and after autoantibody seroconversion (of the cases) using PCs of the oxylipins at those visits. RESULTS: The ARA-related oxylipin 5-HETE was associated with increased type 1 diabetes risk. Five LA-related oxylipins, two ALA-related oxylipins and one DHA-related oxylipin were associated with decreased type 1 diabetes risk. A profile of elevated LA- and ALA-related oxylipins (PC1) was associated with decreased type 1 diabetes risk (OR 0.61; 95% CI 0.40, 0.94). A profile of elevated ARA-related oxylipins (PC2) was associated with increased diabetes risk (OR 1.53; 95% CI 1.03, 2.29). A critical timepoint analysis showed type 1 diabetes was associated with a high ARA-related oxylipin profile at post-autoantibody-seroconversion but not pre-seroconversion. CONCLUSIONS/INTERPRETATION: The protective association of higher LA- and ALA-related oxylipins demonstrates the importance of both inflammation promotion and resolution in type 1 diabetes. Proinflammatory ARA-related oxylipins may play an important role once the autoimmune process has begun.
引用
- Buckner T, Vanderlinden LA, DeFelice BC, et al. The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2021. PMID: 33893822. doi:10.1007/s00125-021-05457-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。